Variant report
Variant | esv2755754 |
---|---|
Chromosome Location | chr1:165423342-165424342 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs878179 | chr1:165423353-165423354 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs377500051 | chr1:165423362-165423363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192848812 | chr1:165423367-165423368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575406735 | chr1:165423394-165423395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114988793 | chr1:165423414-165423415 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79980989 | chr1:165423492-165423493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184691067 | chr1:165423531-165423532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149476103 | chr1:165423532-165423533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559685537 | chr1:165423545-165423546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528711868 | chr1:165423557-165423558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375109778 | chr1:165423570-165423571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs16845022 | chr1:165423596-165423597 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs531130305 | chr1:165423617-165423618 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550522157 | chr1:165423633-165423634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189636796 | chr1:165423636-165423637 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536344495 | chr1:165423646-165423647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553460083 | chr1:165423660-165423661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566536077 | chr1:165423691-165423692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538794484 | chr1:165423739-165423740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116214016 | chr1:165423791-165423792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575565189 | chr1:165423795-165423796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574742723 | chr1:165423796-165423797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192271823 | chr1:165423833-165423834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184732298 | chr1:165423853-165423854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540305488 | chr1:165423858-165423859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7536062 | chr1:165423876-165423877 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs559427653 | chr1:165423909-165423910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576879748 | chr1:165423926-165423927 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141972144 | chr1:165424007-165424008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565339263 | chr1:165424008-165424009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531100874 | chr1:165424022-165424023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147324089 | chr1:165424075-165424076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569008690 | chr1:165424089-165424090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544804645 | chr1:165424106-165424107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114252070 | chr1:165424149-165424150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7536331 | chr1:165424170-165424171 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs12354373 | chr1:165424226-165424227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201917107 | chr1:165424233-165424234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532818963 | chr1:165424234-165424235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10595057 | chr1:165424246-165424247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs199547406 | chr1:165424247-165424248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113980813 | chr1:165424248-165424249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111666615 | chr1:165424283-165424284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552307417 | chr1:165424322-165424323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551323973 | chr1:165424334-165424335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7513598 | chr1:165424335-165424336 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20409316 | CNVD |
Mental retardation | 17847001 | CNVD |
Idiopathic thrombocytopenic purpura | 17827395 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:165420400-165424400 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr1:165422200-165433200 | Weak transcription | Right Ventricle | heart |
3 | chr1:165422400-165423600 | Weak transcription | Fetal Muscle Trunk | muscle |
4 | chr1:165422400-165423800 | Enhancers | Fetal Heart | heart |
5 | chr1:165423000-165423400 | Enhancers | HSMMtube | muscle |
6 | chr1:165423200-165424000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr1:165423200-165425400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr1:165423600-165424400 | Enhancers | Fetal Muscle Trunk | muscle |
9 | chr1:165424000-165434800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |